LQAI yields 1.11% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, LQAI + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LQAI + MRK for your $10,000?
LQAI launches through a partnership between the AI research division of LG, the South Korean company that makes TVs and home appliances, and Qraft Tech. The fund employs a proprietary artificial intelligence (AI) system for selection while maintaining oversight from the fund's adviser. The AI identifies patterns and creates a balanced exposure to the five factors influencing the US market: quality (profitability), size (market capitalization), value (price-to-book ratio), momentum, and volatility. The fund evaluates the impact of each factor on companies and selects the top 100 stocks based on the average distribution of each stock's relative superiority in price appreciation. These stocks are also poised to outperform their peers in the upcoming month. Due to the monthly updates to the database, LQAI is expected to trade securities frequently, potentially resulting in a high portfolio turnover. The Fund restricts single company weightings to 10% and securities with over 5% weighting to 40% of assets in aggregate. Although investments are heavily reliant on QRAFT AI recommendations, the adviser maintains the final decision-making authority in investment choices.
Full LQAI Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.